The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 11, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 7
- 0 vs. Q3 2021
- Portfolio value
- $735.3M
- −$143.8M (−16.4%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NGMNGM Biopharmaceuticals Inc | COM | 15,396,116 | $272.7M | 37.1% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $178.1M | 24.2% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 3,347,245 | $84.3M | 11.5% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 9,414,795 | $60.6M | 8.2% | +166,666+1.8% | Added | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,568,181 | $52.5M | 7.1% | −1,200,000−25.2% | Reduced | History |
| RAPTRAPT Therapeutics, Inc. | COM | 1,402,008 | $51.5M | 7.0% | 00.0% | Unchanged | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,309,329 | $35.7M | 4.9% | 00.0% | Unchanged | History |